TrialBMC cancer2025

The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy.

Hui Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.